In 2000, he received a master's degree in science from Wuhan University and a doctor's degree in medicine from Chongqing Medical University in 2005. From March 20, 2 009 to April 0, 2009, he worked in NIH NIAID, USA 20 10/year (visiting scholar). Comrade Ma Yongping is serious and responsible for teaching and scientific research, with a rigorous style and high academic level and scientific research ability. Since 2002, he has presided over 4 national natural sciences and Chongqing Key Teacher Program 1, obtained 2 national invention patents, applied for 4 national inventions, participated in 2 monographs such as Bioanalytical Chemistry and Clinical protein Histology, and published more than 0 professional papers1. In recent years, with Bifidobacterium as expression vector, extensive research has been carried out in genetic engineering vaccine and tumor gene therapy. At present, the main research directions are: genetically engineered vaccines and drugs, tumor-targeted gene therapy vectors and their technologies. Main research interests: genetically engineered vaccines and tumor-targeted gene therapy.